Literature DB >> 26631969

miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1.

Guoqiang Zhang1, Zengyan Liu2, Hao Xu3, Qifeng Yang4.   

Abstract

Altered levels and functions of microRNAs (miRNAs) are correlated with carcinogenesis. While miR-409-3p has been shown to play important roles in several cancer types, its function in the context of breast cancer (BC) remains unknown. In this study, miR-409-3p was significantly downregulated in BC tissues and cell lines, compared with the corresponding control counterparts. Overexpression of miR-409-3p inhibited BC cell proliferation, migration and invasion in vitro and suppressed tumor growth in vivo. Notably, miR-409-3p induced downregulation of Akt1 protein through binding to its 3' untranslated region (UTR). Conversely, restoring Akt1 expression rescued the suppressive effects of miR-409-3p. Our data collectively indicate that miR-409-3p functions as a tumor suppressor in BC through downregulating Akt1, supporting the targeting of the novel miR-409-3p/Akt1 axis as a potentially effective therapeutic approach for BC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt1; Breast cancer; Invasion; Proliferation; miR-409-3p

Mesh:

Substances:

Year:  2015        PMID: 26631969     DOI: 10.1016/j.bbrc.2015.11.099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Network analysis identifies common genes associated with obesity in six obesity-related diseases.

Authors:  Li-Ning Su; Yan-Bing Wang; Chun-Guang Wnag; Hui-Ping Wei
Journal:  J Zhejiang Univ Sci B       Date:  2017 Aug.       Impact factor: 3.066

2.  MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.

Authors:  Zhijun Zhao; Fei Yang; Yan Liu; Kai Fu; Shanghua Jing
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

3.  miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.

Authors:  Peng Ma; Kan Ni; Jing Ke; Wenyi Zhang; Ying Feng; Qinsheng Mao
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-25

4.  MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1.

Authors:  Jian Yao; Ping Zhang; Jin Li; Wei Xu
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

5.  miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX.

Authors:  Hujie Chen; Jing Dai
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

6.  Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway.

Authors:  Ke Ye; Jindong Li; Xinying Li; Shi Chang; Zhejia Zhang
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

7.  CircRNA DOCK1 Regulates miR-409-3p/MCL1 Axis to Modulate Proliferation and Apoptosis of Human Brain Vascular Smooth Muscle Cells.

Authors:  Xinmin Ding; Xiaolong Wang; Li Han; Zhiyu Zhao; Shuai Jia; Yuanzhao Tuo
Journal:  Front Cell Dev Biol       Date:  2021-05-24

8.  AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.

Authors:  Ye Cheng; Gang Zhao; Siwen Zhang; Fares Nigim; Guangtong Zhou; Zhiyun Yu; Yang Song; Yong Chen; Yunqian Li
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.

Authors:  Lingshuang Lü; Jian Sun; Peiyi Shi; Weimin Kong; Kun Xu; Biyu He; Simin Zhang; Jianming Wang
Journal:  Oncotarget       Date:  2017-07-04

10.  A Central Bioactive Region of LTBP-2 Stimulates the Expression of TGF-β1 in Fibroblasts via Akt and p38 Signalling Pathways.

Authors:  Mohamed A Sideek; Joshua Smith; Clementine Menz; Julian R J Adams; Allison J Cowin; Mark A Gibson
Journal:  Int J Mol Sci       Date:  2017-10-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.